mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |